Evidence map›Paper›PMID 30552818›Full record

ReviewImmunology2019

Developmental origins of murine γδ T-cell subsets.

Nital Sumaria, Stefania Martin, Daniel J Pennington

Abstract readReview
In one paragraph

Review in Immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Topoisomerase 1 is required for the development and function of thymus.Journal of immunology (Baltimore, Md. : 1950) · 2025
    Article
  3. Conserved moonlighting protein pyruvate dehydrogenase induces robust protection againstProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. Article
  5. Article
  6. Review
  7. γδ T cells: origin and fate, subsets, diseases and immunotherapy.Signal transduction and targeted therapy · 2023
    Review
  8. RNA mProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  9. Review
  10. Review
  11. Akt isoforms in the immune system.Frontiers in immunology · 2022
    Review
  12. The association ofFrontiers in neurology · 2022
    Article
  13. γδ T cells in tissue physiology and surveillance.Nature reviews. Immunology · 2021
    Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nital SumariaBlizard Institute, Barts and The London School of Medicine, Queen Mary University of London, London, UK.
Stefania MartinBlizard Institute, Barts and The London School of Medicine, Queen Mary University of London, London, UK.
Daniel J PenningtonBlizard Institute, Barts and The London School of Medicine, Queen Mary University of London, London, UK.

Funding

BBSRC BB/R017808/1Wellcome TrustWellcome Trust 092973/Z/10/Z
6 · The paper itself

Abstract

Murine γδ T cells display diverse responses to pathogens and tumours through early provision of pro-inflammatory cytokines such as interleukin-17A (IL-17) and interferon-γ (IFN-γ). Although it is now clear that acquisition of these cytokine-secreting effector fates is to a great extent developmentally pre-programmed in the thymus, the stages through which γδ progenitor cells transition, and the underlying mechanistic processes that govern these commitment events, are still largely unclear. Here, we review recent progress in the field, with particular consideration of how TCR-γδ signalling impacts on developmental programmes initiated before TCR-γδ expression.

Indexed as

AnimalsMiceReceptors, Antigen, T-Cell, gamma-deltaSignal TransductionT-Lymphocyte SubsetsReceptors, Antigen, T-Cell, gamma-deltaIFN-γIL-17T-cell developmentTCR-γδthymusγδ T cells

Identifiers

PMID30552818
PMCPMC6418442

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.